vs

Side-by-side financial comparison of Cellebrite DI Ltd. (CLBT) and INTERPARFUMS INC (IPAR). Click either name above to swap in a different company.

INTERPARFUMS INC is the larger business by last-quarter revenue ($386.2M vs $292.2M, roughly 1.3× Cellebrite DI Ltd.). INTERPARFUMS INC runs the higher net margin — 7.3% vs -103.5%, a 110.7% gap on every dollar of revenue. INTERPARFUMS INC produced more free cash flow last quarter ($145.0M vs $60.8M). Over the past eight quarters, Cellebrite DI Ltd.'s revenue compounded faster (72.8% CAGR vs 9.2%).

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

Inter Parfums Inc is a global prestige fragrance firm that develops, manufactures and distributes perfumes, body care and related cosmetics. It partners with top luxury fashion and lifestyle brands to launch licensed fragrance lines, serving consumers across North America, Europe, Asia Pacific and other key markets via department stores, beauty retailers and official e-commerce channels.

CLBT vs IPAR — Head-to-Head

Bigger by revenue
IPAR
IPAR
1.3× larger
IPAR
$386.2M
$292.2M
CLBT
Higher net margin
IPAR
IPAR
110.7% more per $
IPAR
7.3%
-103.5%
CLBT
More free cash flow
IPAR
IPAR
$84.2M more FCF
IPAR
$145.0M
$60.8M
CLBT
Faster 2-yr revenue CAGR
CLBT
CLBT
Annualised
CLBT
72.8%
9.2%
IPAR

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CLBT
CLBT
IPAR
IPAR
Revenue
$292.2M
$386.2M
Net Profit
$-302.3M
$28.1M
Gross Margin
84.6%
61.5%
Operating Margin
14.1%
7.1%
Net Margin
-103.5%
7.3%
Revenue YoY
6.8%
Net Profit YoY
16.0%
EPS (diluted)
$-1.50
$0.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLBT
CLBT
IPAR
IPAR
Q4 25
$386.2M
Q3 25
$292.2M
$429.6M
Q2 25
$220.8M
$333.9M
Q1 25
$89.6M
$338.8M
Q4 24
$361.5M
Q3 24
$232.1M
$424.6M
Q2 24
$185.3M
$342.2M
Q1 24
$71.2M
$324.0M
Net Profit
CLBT
CLBT
IPAR
IPAR
Q4 25
$28.1M
Q3 25
$-302.3M
$65.8M
Q2 25
$36.9M
$32.0M
Q1 25
$-71.4M
$42.5M
Q4 24
$24.2M
Q3 24
$62.3M
Q2 24
$-95.2M
$36.8M
Q1 24
$-40.6M
$41.0M
Gross Margin
CLBT
CLBT
IPAR
IPAR
Q4 25
61.5%
Q3 25
84.6%
63.5%
Q2 25
84.1%
66.2%
Q1 25
85.2%
63.7%
Q4 24
64.5%
Q3 24
83.5%
63.9%
Q2 24
84.1%
64.5%
Q1 24
82.6%
62.5%
Operating Margin
CLBT
CLBT
IPAR
IPAR
Q4 25
7.1%
Q3 25
14.1%
25.3%
Q2 25
12.1%
17.7%
Q1 25
10.3%
22.2%
Q4 24
10.0%
Q3 24
7.9%
25.0%
Q2 24
11.7%
18.9%
Q1 24
0.2%
21.0%
Net Margin
CLBT
CLBT
IPAR
IPAR
Q4 25
7.3%
Q3 25
-103.5%
15.3%
Q2 25
16.7%
9.6%
Q1 25
-79.7%
12.5%
Q4 24
6.7%
Q3 24
14.7%
Q2 24
-51.4%
10.8%
Q1 24
-57.0%
12.7%
EPS (diluted)
CLBT
CLBT
IPAR
IPAR
Q4 25
$0.88
Q3 25
$-1.50
$2.05
Q2 25
$0.15
$0.99
Q1 25
$-0.36
$1.32
Q4 24
$0.78
Q3 24
$-0.35
$1.93
Q2 24
$-0.48
$1.14
Q1 24
$-0.21
$1.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLBT
CLBT
IPAR
IPAR
Cash + ST InvestmentsLiquidity on hand
$191.7M
$137.1M
Total DebtLower is stronger
$176.0M
Stockholders' EquityBook value
$336.0M
$880.7M
Total Assets
$690.6M
$1.6B
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLBT
CLBT
IPAR
IPAR
Q4 25
$137.1M
Q3 25
$191.7M
$77.5M
Q2 25
$326.1M
$53.9M
Q1 25
$191.7M
$75.3M
Q4 24
$109.3M
Q3 24
$189.5M
$78.8M
Q2 24
$178.6M
$37.7M
Q1 24
$189.5M
$76.1M
Total Debt
CLBT
CLBT
IPAR
IPAR
Q4 25
$176.0M
Q3 25
Q2 25
Q1 25
Q4 24
$157.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLBT
CLBT
IPAR
IPAR
Q4 25
$880.7M
Q3 25
$336.0M
$870.9M
Q2 25
$408.4M
$839.4M
Q1 25
$336.0M
$788.6M
Q4 24
$744.9M
Q3 24
$34.2M
$778.5M
Q2 24
$-40.2M
$717.1M
Q1 24
$34.2M
$708.1M
Total Assets
CLBT
CLBT
IPAR
IPAR
Q4 25
$1.6B
Q3 25
$690.6M
$1.6B
Q2 25
$787.4M
$1.6B
Q1 25
$690.6M
$1.4B
Q4 24
$1.4B
Q3 24
$532.9M
$1.5B
Q2 24
$556.6M
$1.4B
Q1 24
$532.9M
$1.3B
Debt / Equity
CLBT
CLBT
IPAR
IPAR
Q4 25
0.20×
Q3 25
Q2 25
Q1 25
Q4 24
0.21×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLBT
CLBT
IPAR
IPAR
Operating Cash FlowLast quarter
$66.2M
$146.5M
Free Cash FlowOCF − Capex
$60.8M
$145.0M
FCF MarginFCF / Revenue
20.8%
37.5%
Capex IntensityCapex / Revenue
1.8%
0.4%
Cash ConversionOCF / Net Profit
5.21×
TTM Free Cash FlowTrailing 4 quarters
$172.1M
$190.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLBT
CLBT
IPAR
IPAR
Q4 25
$146.5M
Q3 25
$66.2M
$63.9M
Q2 25
$53.5M
$11.9M
Q1 25
$10.0M
$-7.4M
Q4 24
$138.0M
Q3 24
$58.2M
$76.1M
Q2 24
$24.6M
$25.5M
Q1 24
$12.5M
$-52.0M
Free Cash Flow
CLBT
CLBT
IPAR
IPAR
Q4 25
$145.0M
Q3 25
$60.8M
$57.6M
Q2 25
$47.5M
$-3.3M
Q1 25
$8.5M
$-8.8M
Q4 24
$136.1M
Q3 24
$55.3M
$75.4M
Q2 24
$21.0M
$24.4M
Q1 24
$11.4M
$-53.0M
FCF Margin
CLBT
CLBT
IPAR
IPAR
Q4 25
37.5%
Q3 25
20.8%
13.4%
Q2 25
21.5%
-1.0%
Q1 25
9.5%
-2.6%
Q4 24
37.7%
Q3 24
23.8%
17.8%
Q2 24
11.3%
7.1%
Q1 24
16.0%
-16.4%
Capex Intensity
CLBT
CLBT
IPAR
IPAR
Q4 25
0.4%
Q3 25
1.8%
1.5%
Q2 25
2.7%
4.5%
Q1 25
1.7%
0.4%
Q4 24
0.5%
Q3 24
1.3%
0.2%
Q2 24
1.9%
0.3%
Q1 24
1.5%
0.3%
Cash Conversion
CLBT
CLBT
IPAR
IPAR
Q4 25
5.21×
Q3 25
0.97×
Q2 25
1.45×
0.37×
Q1 25
-0.17×
Q4 24
5.69×
Q3 24
1.22×
Q2 24
0.69×
Q1 24
-1.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

IPAR
IPAR

European Based Operations$232.7M60%
United States Based Operations$155.2M40%

Related Comparisons